THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA: A PILOT STUDY.
THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA: A PILOT STUDY. From the journal Retina.
Please click here to read the article.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.